Skip to content

Clinical trials

Terminated Phase 3 Adenocarcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Phase: Phase 3 Status: Terminated Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20101
20111
20161
20191
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott1
Assistance Publique - Hôpitaux de Paris1
CHIR-Net1
Hoffmann-La Roche1
NuCana plc1
Pharmexa A/S1
UNICANCER1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma7
Neoplasms3
Pancreatic Neoplasms3
Carcinoma2
Digestive System Neoplasms2
Neoplasms by Histologic Type2
Neoplasms by Site2
Biliary Tract Neoplasms1
Bronchial Diseases1
Carcinoma, Adenosquamous1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.